Genitourinary Cancer,RCC (Renal Cell Carcinoma) Comparing Adjuvant Atezolizumab vs. Placebo in RCC Patients at High Risk of Recurrence: IMmotion010 Phase 3 Trial Apr 17, 2023
Genitourinary Cancer,RCC (Renal Cell Carcinoma) TiNivo-2 Trial: Tivozanib Plus Nivolumab vs. Tivozanib Alone in RCC Mar 27, 2023
Genitourinary Cancer,RCC (Renal Cell Carcinoma) Molecular Profiling of RCC Tumors in S-TRAC Anti-Angiogenic Adjuvant Therapy Trial Mar 27, 2023
Genitourinary Cancer,RCC (Renal Cell Carcinoma) Phase 3 Trial of Pembrolizumab and Belzutifan for ccRCC: LITESPARK-022 Mar 27, 2023
Genitourinary Cancer,RCC (Renal Cell Carcinoma) Savolitinib + Durvalumab Monotherapy for Genomic PRCC Abnormalities Mar 27, 2023
Genitourinary Cancer,RCC (Renal Cell Carcinoma) ZIRCON Trial: Noninvasive Detection of ccRCC Using 89Zr-DFO-girentuximab Mar 27, 2023
Bladder Cancer,Genitourinary Cancer CheckMate 274 Trial: Adjuvant Nivolumab vs Placebo in MIUC Analysis Mar 14, 2023
Bladder Cancer,Genitourinary Cancer JAVELIN Bladder 100: Avelumab for Advanced UC in Subgroups Mar 14, 2023
